<img src="https://ml.globenewswire.com/Resource/Download/1630843d-d109-4819-9c6f-455c684690ba?size=2" nborder="0" align="left" hspace="5" vspace="5" title="SIBN_logo.jpg" alt="SI-BONE, Inc."/>SANTA CLARA, Calif., Aug. 31, 2026 <a href="https://www.globenewswire.com" target="_blank">(GLOBE NEWSWIRE)</a> -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming 2026 Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY. Management will be hosting a fireside chat on Monday, September 14, 2026, at 8:30 a.m. Pacific Time/ 11:30 a.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link: <a href="https://www.globenewswire.com/Tracker?data=M1pA_jPcyIdkPg220wILhyvlJf7krke3bgs44WjgfCvVr_bYDhI3SXyK6ADWqgnbvIQvfru5IHAummGjbyx_twSSP-ayxVgIGgwqprByamHlIMM6NmIkrF1P0y8zGvuQsjp8nErMJsMXSkyh_tge5rYxZRNrDXK20EpbAzG8j5ij28rmeunpkVZKugYb1Pp8" rel="nofollow" target="_blank" title="SI-BONE, Inc. - 1774169">SI-BONE, Inc. - 1774169</a>. Live audio of the webcast will be available on the “Investors” section of the company’s website at: <a href="https://www.globenewswire.com/Tracker?data=wVZvYHVzJeyRpH8oSlXtRpg5pXB-gZTbw3j8L2uD7RwEXpXI0lLc1f4nhOApBttx_3kf0wgD-dEBJX4lZZ0iFQ==" rel="nofollow" target="_blank" title="www.si-bone.com">www.si-bone.com</a>. The webcast will be archived and available for replay for at least 90 days after the event. About SI-BONE, Inc. SI-BONE (NASDAQ: SIBN) is a global leader in developing procedural solutions to address clinical challenges associated with compromised bone. With expertise in biomechanical design and anatomy specific innovation, SI-BONE has built a technology platform with market-leading applications centered on the spinopelvic anatomy. SI-BONE continues to leverage the deep experience in addressing the challenges of low-density bone in the sacrum to develop unique technologies that are targeting new clinical adjacencies to help improve outcomes for patients with compromised bone. Since 2009, SI-BONE has supported physicians in performing a total of over 150,000 procedures. A unique body of clinical evidence supports the use of SI-BONE's technologies, including four randomized controlled trials and over 190 peer reviewed publications. For additional information on the company or the products, including risks and benefits, please visit <a href="https://www.globenewswire.com/Tracker?data=wVZvYHVzJeyRpH8oSlXtRjSS9qD2hNk9jGd9FgJ1APpB7kAzNmTEb_4jYtB7tZvc6a_0xpOL4hl4WRD1y94vuwFCoTSkHCdXcL1EjNEBdps=" rel="nofollow" target="_blank" title="www.si-bone.com">www.si-bone.com</a>. SI-BONE® is a registered trademark of SI-BONE, Inc. ©2026 SI-BONE, Inc. All Rights Reserved. Investor Contact Saqib Iqbal VP, FP&amp;A, and Investor Relations investors@SI-BONE.com <img alt="" src='https://ml.globenewswire.com/media/NmIzMDc2YzUtMzQ1OC00ZTNmLTg0MWItOWZjMjcyNDVlZDYxLTExMzUyNTMtMjAyNi0wOC0zMS1lbg==/tiny/SI-BONE-Inc-.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn